Differential protein expression in the epidermis of wild-type and COX-2 transgenic mice

被引:6
作者
Mueller-Decker, K.
Fuerstenberger, G.
Neumann, M.
Schnoelzer, M.
机构
[1] German Canc Res Ctr, Eicosanoids & Tumor Dev Sect, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Prot Anal Facil, D-69120 Heidelberg, Germany
关键词
cyclooxygenase; prostaglandins; transgenic epidermis; hair follicle biology; squamous cell carcinoma;
D O I
10.1159/000091975
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Cyclooxygenases (COX) 1 and 2 are the key enzymes of prostaglandin biosynthesis. Like in many tissues, in adult skin COX-1 is a constitutive 'housekeeping' enzyme, while COX-2 is induced transiently in stress situations such as tissue damage and regeneration. In human skin carcinomas and corresponding early-stage cancer lesions, permanent COX-2 expression and activation is a consistent feature. Knockout and various transgenic approaches and pharmacologic studies show strong evidence for a cause-and-effect relationship between the aberrant COX-2 activation and tumor formation. In skin epidermis, keratin 5 promoter-driven overexpression of COX-2 caused hyperplasia and dysplasia, and sensitized skin for carcinogenesis. Therefore, this model offers the unique possibility of identifying COX-2-dependent and prostaglandin-mediated molecular pathways leading to the formation and malignant progression of early-stage cancer lesions.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 33 条
[1]  
Chulada PC, 2000, CANCER RES, V60, P4705
[2]   Cyclooxygenase-2 and epidermal growth factor receptor: Pharmacologic targets for chemoprevention [J].
Dannenberg, AJ ;
Lippman, SM ;
Mann, JR ;
Subbaramaiah, K ;
DuBois, RN .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (02) :254-266
[3]  
Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cellbio.11.1.123
[4]   Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? [J].
Gasparini, G ;
Longo, R ;
Sarmiento, R ;
Morabito, A .
LANCET ONCOLOGY, 2003, 4 (10) :605-615
[5]   Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 [J].
Gupta, RA ;
DuBois, RN .
NATURE REVIEWS CANCER, 2001, 1 (01) :11-21
[6]   Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair [J].
Kämpfer, H ;
Bräutigam, L ;
Geisslinger, G ;
Pfeilschifter, J ;
Frank, S .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (05) :880-890
[7]   Transitional cell hyperplasia and carcinomas in urinary bladders of Transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression [J].
Klein, RD ;
Van Pelt, CS ;
Sabichi, AL ;
dela Cerda, J ;
Fischer, SM ;
Fürstenberger, G ;
Müller-Decker, K .
CANCER RESEARCH, 2005, 65 (05) :1808-1813
[8]   Cyclooxygenases in the skin: pharmacological and toxicological implications [J].
Lee, JL ;
Mukhtar, H ;
Bickers, DR ;
Kopelovich, L ;
Athar, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 192 (03) :294-306
[9]   Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice [J].
Liu, CH ;
Chang, SH ;
Narko, K ;
Trifan, OC ;
Wu, MT ;
Smith, E ;
Haudenschild, C ;
Lane, TF ;
Hla, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :18563-18569
[10]   Cancer chemoprevention through interruption of multistage carcinogenesis:: the lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer [J].
Marks, F ;
Fürstenberger, G .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (03) :314-329